glp 1 and gip agonist glp-1 receptor Targeting GLP-1, & GCG in Obesity Type 2 Diabetes Research Demonstrated metabolic effects of GIP, – Schematic illustration of monoagonists, dual

Preclinical modeling of surgery and steroid therapy for glioblastoma reveals changes in immunophenotype that are associated with tumor growth and outcome

Holistic Approach We believe in treating the whole person, not just the symptoms

Gigliotti contrasts such a patient with a person who has a BMI of 40 and diagnoses of hypertension, type 2 diabetes, CVD, and musculoskeletal issues, who may benefit from lifelong use of weight management medications

In addition, this method has also been used in biomarker research for diseases such as diabetes and obesity

While choline shows therapeutic potential, such as reducing inflammation and supporting cognitive and liver health, it can also contribute to disease, including increased risk of cardiovascular events or cancer progression